» Authors » Esteban Zavaleta-Monestel

Esteban Zavaleta-Monestel

Explore the profile of Esteban Zavaleta-Monestel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 23
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Villalobos-Madriz J, Zavaleta-Monestel E, Martinez-Vargas E, Fallas-Mora A, Prado-Rivero M, Bastos-Soto N, et al.
Cureus . 2025 Mar; 17(2):e78693. PMID: 40062057
Introduction: Medication errors pose significant risks to patient safety and healthcare quality. This study analyzes the practices of identification and management of these errors in private hospitals in Costa Rica...
2.
Zavaleta-Monestel E, Anchia-Alfaro A, Rojas-Chinchilla C, Quesada-Loria D, Arguedas-Chacon S
Cureus . 2025 Mar; 17(2):e78416. PMID: 40046390
Introduction Artificial intelligence (AI) transforms medicine by enhancing diagnoses, treatments, resource management, and personalized treatment plans. However, it poses ethical and legal challenges, such as data privacy and equitable access...
3.
Zavaleta-Monestel E, Rojas-Chinchilla C, Campos-Hernandez J, Martinez-Vargas E
Cureus . 2025 Mar; 17(1):e78296. PMID: 40027042
Antimicrobial resistance (AMR) is a growing public health issue, complicating the treatment of bacterial infections and increasing morbidity and mortality globally. This phenomenon, which occurs as a result of the...
4.
Zavaleta-Monestel E, Rojas-Chinchilla C, Molina-Sojo P, Murillo-Castro M, Rojas-Molina J, Martinez-Vargas E
Cureus . 2025 Feb; 17(1):e77972. PMID: 39996198
Climate change has significantly altered the dynamics of vector-borne infectious diseases, favoring their proliferation and geographic expansion. Factors such as rising temperatures, the frequency of extreme weather events, and uncontrolled...
5.
Zavaleta-Monestel E, Quesada-Villasenor R, Barrantes-Lopez M, Arguedas-Chacon S, Campos-Hernandez J, Rojas-Chinchilla C, et al.
Cureus . 2025 Jan; 16(12):e74970. PMID: 39744254
Multiple myeloma (MM) is the second most common hematological malignancy globally. Despite its reputation as an aggressive and fatal disease, recent advancements in treatment have significantly improved patient outcomes. Over...
6.
Zavaleta-Monestel E, Anchia-Alfaro A, Villalobos-Madriz J, Munich A, Garcia-Montero J, Quesada-Villasenor R, et al.
Cureus . 2024 Dec; 16(11):e74307. PMID: 39717323
Pain is a prevalent issue among patients, requiring effective management to prevent the transition of acute pain into chronic pain and to mitigate significant clinical and socioeconomic impacts, such as...
7.
Diaz-Madriz J, Rojas-Chinchilla C, Zavaleta-Monestel E, Ching-Fung S, Marin-Piva H, Marin G, et al.
BMC Public Health . 2024 Nov; 24(1):3205. PMID: 39558349
Background: Antimicrobial resistance is a significant global health threat. Therefore, robust surveillance systems for antimicrobial consumption (AMC) are essential to develop public health strategies. However, Latin American countries, including Costa...
8.
Zavaleta-Monestel E, Martinez-Vargas E, Chaverri-Fernandez J, Diaz-Madriz J, Fallas-Mora A, Alvarado-Ajun P, et al.
Cureus . 2024 Oct; 16(9):e70007. PMID: 39445302
Introduction:  Delirium is a common and serious neurological complication in intensive care units (ICUs), often leading to poor patient outcomes and increased mortality. This study aimed to compare the incidence...
9.
Zavaleta-Monestel E, Rojas-Barrantes Z, Diaz-Madriz J, Arguedas-Chacon S, Cordero-Garcia E, Chaverri-Fernandez J
Cureus . 2024 Oct; 16(9):e68998. PMID: 39385894
Background The seamless management of transitions of care (TOC) is necessary for patient safety, as it directly correlates with a heightened risk of medication errors and adverse effects. Clinical pharmacists...
10.
Zavaleta-Monestel E, Garcia-Montero J, Anchia-Alfaro A, Rojas-Chinchilla C, Quesada-Villasenor R, Arguedas-Chacon S, et al.
Cureus . 2024 Sep; 16(8):e67314. PMID: 39301338
Checkpoints are essential proteins in the immune system that regulate the intensity and duration of immune responses, preventing damage to healthy tissues during the fight against pathogens and abnormal cells....